Tg Therapeutics Inc (TGTX)

R&D Expenses

$95.34M

Quarterly · Period ending: · USD

TGTX logo

TGTX R&D Expenses

Latest reported$95.34M
TGTX Quarterly R&D Expenses ($0.00 → $95.34M)
High-resolution chart · PNG

TGTX r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Tg Therapeutics Inc R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
95,337,000
48,396,000
41,193,000
40,878,000
31,782,000
46,362,000
23,874,000
20,138,000
17,556,000
32,722,000
17,449,000
14,753,000
22,458,000
15,870,000
29,635,000
20,801,000
26,874,000
48,042,000
62,646,000
51,967,000
44,871,000
63,094,000
42,961,000
50,464,000
36,449,000
36,022,000
29,454,000
56,503,000
31,514,000
30,896,000
51,069,000
32,754,000
37,812,000
32,159,000
25,736,101
25,334,762
25,439,477
20,375,794
21,414,723
20,878,108
12,966,574
11,230,415
13,725,926
11,538,246
9,902,214
8,279,431
12,807,504
12,490,998
3,548,021
2,508,258
3,606,385
3,138,119
4,661,455
1,215,202
860,222
1,560,802
1,646,094
16,741,353
-214,009
95,897
90,218
355,177
190,293
236,734
50,999
17,767
-16,778
5,574
6,644
44,936
-61,860
498,853
565,728
800,071
1,175,647
1,808,958
3,871,634
1,679,448
1,924,695
1,023,447
1,453,811
2,023,319
13,773,876
1,370,733
957,235
964,040
1,245,821
1,678,939
518,961
709,273
989,692
377,820
313,176
43,355
72,599
125,376
139,935
201,842
112,376
172,257
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.